Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice - Concepedia

Concepedia

Publication | Closed Access

Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice

46

Citations

17

References

2018

Year

Shinsuke Uchikawa, Tomokazu Kawaoka, Hiroshi Aikata, Kenichiro Kodama, Yuno Nishida, Yuki Inagaki, Masahiro Hatooka, Kei Morio, Takashi Nakahara, Eisuke Murakami,

Hepatology Research

Abstract

Among patients with PD on sorafenib, approximately 30% were eligible for regorafenib treatment, whereas few patients with MVI or hypoalbuminemia at sorafenib initiation were eligible for regorafenib treatment.

References

	Year	Citations

Page 1